85 related articles for article (PubMed ID: 20201748)
1. A role for CYP in the drug-hormone crosstalk of the brain.
Meyer RP; Gehlhaus M
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):675-87. PubMed ID: 20201748
[TBL] [Abstract][Full Text] [Related]
2. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
Lewis DF; Ito Y
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotics in the limbic system--affecting brain's network function.
Meyer RP; Pantazis G; Killer N; Bürck C; Schwab R; Brandt M; Knoth R; Gehlhaus M
Vitam Horm; 2010; 82():87-106. PubMed ID: 20472134
[TBL] [Abstract][Full Text] [Related]
4. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment.
Meyer RP; Gehlhaus M; Schwab R; Bürck C; Knoth R; Hagemeyer CE
J Neurochem; 2009 Apr; 109(2):670-81. PubMed ID: 19226368
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
Murray M
Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
[TBL] [Abstract][Full Text] [Related]
6. Cytochromes P450: decision-making tools for personalized therapeutics.
Murray M; Petrovic N
Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
[TBL] [Abstract][Full Text] [Related]
7. Effect of lindane on CYP-mediated steroid hormone metabolism in male mice following in utero exposure.
Di Consiglio E; De Angelis G; Traina ME; Urbani E; Testai E
J Appl Toxicol; 2009 Nov; 29(8):648-55. PubMed ID: 19557771
[TBL] [Abstract][Full Text] [Related]
8. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage.
Pieper IA; Bertau M
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):747-60. PubMed ID: 20367108
[TBL] [Abstract][Full Text] [Related]
9. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity.
Oesch-Bartlomowicz B; Oesch F
Biol Chem; 2002 Oct; 383(10):1587-92. PubMed ID: 12452435
[TBL] [Abstract][Full Text] [Related]
10. Updates on cytochrome P450-mediated cardiovascular drug interactions.
Cheng JW; Frishman WH; Aronow WS
Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450-mediated metabolism in the human gut wall.
Thelen K; Dressman JB
J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
[TBL] [Abstract][Full Text] [Related]
12. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
Muruganandan S; Sinal CJ
Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression.
Chen JT; Chen RM
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):273-81. PubMed ID: 20163319
[TBL] [Abstract][Full Text] [Related]
14. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat.
Wójcikowski J; Daniel WA
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):631-45. PubMed ID: 19442036
[TBL] [Abstract][Full Text] [Related]
15. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.
Birzniece V; Bäckström T; Johansson IM; Lindblad C; Lundgren P; Löfgren M; Olsson T; Ragagnin G; Taube M; Turkmen S; Wahlström G; Wang MD; Wihlbäck AC; Zhu D
Brain Res Rev; 2006 Aug; 51(2):212-39. PubMed ID: 16368148
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
17. Interactive binding at cytochrome P-450 of cell growth regulatory bioamines, steroid hormones, antihormones, and drugs.
LaBella FS; Queen GM; Brandes LJ
J Cell Biochem; 2000 Jan; 76(4):686-94. PubMed ID: 10653987
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.
Lee CA; Cook JA; Reyner EL; Smith DA
Expert Opin Drug Metab Toxicol; 2010 May; 6(5):603-19. PubMed ID: 20397967
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Induction of drug metabolism: species differences and toxicological relevance.
Graham MJ; Lake BG
Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
